Vanderbilt Health and Eli Lilly are developing an AI agent to speed Alzheimer's disease treatment, with plans for radiology-focused AI tools.
Key Details
- 1Vanderbilt Health received a $600,000 grant from Eli Lilly to build an AI triage agent for Alzheimer's care in the EHR system.
- 2The AI tool will streamline referrals, summarize charts, flag missing details, and prioritize cases, aiming to reduce wait times for monoclonal antibody treatment.
- 3The project will be piloted with data from over 5,300 patients at Vanderbilt Health, targeting reduced time from diagnosis to infusion.
- 4Plans include a second AI agent to analyze MRI images and generate Alzheimer's safety reports for radiologists, and a third to support insurance authorization.
- 5Outcomes will be measured by reduced delays across the dementia care pathway.
Why It Matters
The integration of AI triage and radiology-focused agents aims to address bottlenecks in Alzheimer's care, supporting faster and more accurate treatment. Success here could set a model for scalable, AI-enhanced workflows across radiology and neurology.
Source
EurekAlert
Related News
•EurekAlert
Mayo Clinic Unveils AI-Enabled Clinical Decision Support Platform
Mayo Clinic Platform launches an AI-enabled Clinical Decision Support solution to streamline clinician workflows and provide evidence-based, individualized patient care.
•EurekAlert
AI Model MANTIS Improves Risk Stratification in Pediatric Brain Tumors
Dana-Farber Cancer Institute has developed an AI model, MANTIS, that uses DNA methylation profiling to individualize prognosis and guide therapy for children with brain tumors.
•EurekAlert
Quantum Machine Learning Shows Promise for Lung Cancer Prediction with Limited Data
FAU researchers demonstrate quantum machine learning can accurately predict lung cancer from sparse clinical data sets.